Globus Medical, Inc. GMED
Set alert
At close
Pre-market · Nov 3, 7:24 AM ET
- YTD
- -8.99%
- 1 year
- +31.58%
- Open
- 77.60
- Prev close
- 78.05
- Mkt cap
- 10.67B
- Vol
- 1.51M
- Avg vol
- 1.42M
- EPS
- 3.90
- P/E
- 20.37
- Div yield
- 0.00%
More statistics
- Low
- 77.60
- High
- 80.42
- Forward P/E
- 14.74
- Beta
- 0.95
- Short ratio
- 5.17
- Inst. own
- 94.74%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 77.62
- 200-d avg
- 83.50
- 1y target
- 100.92
2Y chart
Events in this range
- Aug 7, 2025Earnings: 0.86; estimate 0.76; surprise 13.16%
- Nov 6, 2025Earnings: 1.18; estimate 0.781; surprise 51.09%
- Feb 24, 2026Earnings: 1.28; estimate 1.06; surprise 20.75%
- May 7, 2026Earnings: 1.12; estimate 0.92; surprise 21.74%
- Jul 9, 2026Rating: BMO Capital · — → Outperform
- Jul 13, 2026Rating: RBC Capital · Outperform → Outperform
- Jul 16, 2026Rating: Truist Securities · Buy → Buy
- Jul 28, 2026Rating: UBS · — → Neutral
- Aug 6, 2026Earnings: 1.34; estimate 1.1; surprise 21.82%
- Aug 7, 2026Rating: Wells Fargo · Overweight → Overweight
- Oct 1, 2026Rating: RBC Capital · Outperform → Outperform
Signals (92)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| SMA: Bearish | Oct 16, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 15, 2026 | 2 weeks ago |
| MACD: Buy Signal | Sep 25, 2026 | 1 month ago |
| RSI: Oversold | Sep 10, 2026 | 1 month ago |
| SMA: Bearish | Sep 1, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 25, 2026 | 2 months ago |
| SMA: Bearish | Aug 24, 2026 | 2 months ago |
| SMA: Bullish | Aug 18, 2026 | 2 months ago |
| SMA: Bearish | Aug 17, 2026 | 2 months ago |
| SMA: Bullish | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| SMA: Bearish | Jul 31, 2026 | 3 months ago |
| SMA: Bullish | Jul 28, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 27, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 20, 2026 | 3 months ago |
| SMA: Bearish | Jul 17, 2026 | 3 months ago |
| SMA: Bullish | Jul 16, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 16, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 8, 2026 | 3 months ago |
Newest 20 of 92.
Key statistics
- Market cap
- 10.67B
- Enterprise value
- 10.00B
- Trailing P/E
- 20.37
- Forward P/E
- 14.74
- PEG ratio
- 1.49
- Price / sales
- 3.39
- Price / book
- 2.24
- EPS (TTM)
- 3.90
- Beta
- 0.95
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 17.03%
- Revenue (TTM)
- 3.14B
- Revenue growth
- 5.90%
- Free cash flow
- 554.19M
- Total cash
- 595.14M
- Total debt
- 111.91M
- Return on equity
- 11.81%
- Shares outstanding
- 111.83M
- Short % of float
- 7.38%
- 50-day average
- 77.62
- 200-day average
- 83.50
Analyst view
Consensus: buy
- Target (low)
- 84.00
- Target (mean)
- 100.92
- Target (high)
- 125.00
- Strong buy3
- Buy7
- Hold4
- Sell0
- Strong sell0
Next earnings
Nov 5, 2026
Expected Nov 5, 2026. Consensus EPS estimate 1.20.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 5, 2026 | Sep 30, 2026 | 1.20 | — | — | — |
| Aug 6, 2026 | Jun 30, 2026 | 1.10 | 1.34 | +0.24 | +21.82% |
| May 7, 2026 | Mar 31, 2026 | 0.92 | 1.12 | +0.20 | +21.74% |
| Feb 24, 2026 | Dec 31, 2025 | 1.06 | 1.28 | +0.22 | +20.75% |
| Nov 6, 2025 | Sep 30, 2025 | 0.781 | 1.18 | +0.40 | +51.09% |
| Aug 7, 2025 | Jun 30, 2025 | 0.76 | 0.86 | +0.10 | +13.16% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 1, 2026 | RBC Capital | main | Outperform | Outperform |
| Aug 7, 2026 | Wells Fargo | main | Overweight | Overweight |
| Jul 28, 2026 | UBS | init | — | Neutral |
| Jul 16, 2026 | Truist Securities | main | Buy | Buy |
| Jul 13, 2026 | RBC Capital | main | Outperform | Outperform |
| Jul 9, 2026 | BMO Capital | init | — | Outperform |
About Globus Medical, Inc.
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems. In addition, the company offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative and image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cells, tissues, and cellular and tissue-based products. The company sells its products through direct and distributor sales representatives; and independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- globusmedical.com
News
- Globus Medical: The Shrinking Robot Line Hides A Growing Annuity
- GMED vs. AXGN: Which Stock Should Value Investors Buy Now?
- Wall Street Analysts Think Globus Medical (GMED) Could Surge 30.52%: Read This Before Placing a Bet
- Why Globus Medical (GMED) is a Top Momentum Stock for the Long-Term
- 2 Healthcare Technology Stocks for a Digital Health Boom
- Globus Medical Q2 2026 Earnings Call Transcript
- RBC Capital Maintains Outperform on Globus Medical, Lowers Price Target to $85
- Globus Medical Receives CE Mark For Its Excelsius3D Imaging System For Commercial Sale In EU, U.K.
- Globus Medical To Acquire Higgs Boson Health; Financial Terms Not Disclosed
- Wells Fargo Maintains Overweight on Globus Medical, Lowers Price Target to $99
Your note
Sign in to keep a note on GMED — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| DAVIDAR DAVID D | Director | Stock Gift | Jul 26, 2026 | 673,642 |
| KLINE KYLE | Chief Financial Officer | Sale | Jan 7, 2026 | 0 |
| LEMAITRE DANIEL | Director | Sale | Nov 21, 2024 | 0 |
| NORWALK LESLIE V | Director | Sale | Jan 7, 2026 | 10,419 |
| PAUL DAVID C | Officer, Director and Beneficial Owner | Conversion of Exercise of derivative security | Dec 7, 2025 | 60,417 |
| PFEIL KEITH W. | Chief Operating Officer | Sale | Jan 9, 2025 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 8.05% | 10,806,724 | 858.65M | Jun 29, 2026 |
| Jupiter Topco LLC | 6.11% | 8,200,423 | 651.56M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 3.80% | 5,107,532 | 405.82M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 3.72% | 4,994,385 | 396.83M | Jun 29, 2026 |
| Invesco Ltd. | 3.21% | 4,309,771 | 342.43M | Jun 29, 2026 |
| Kayne Anderson Rudnick Investment Management LLC | 3.19% | 4,279,730 | 340.05M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 2.97% | 3,983,485 | 316.51M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.68% | 3,595,564 | 285.69M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 1.93% | 2,597,815 | 206.41M | Jun 29, 2026 |
| JANUS INVESTMENT FUND-Janus Henderson Enterprise Fund | 1.64% | 2,207,141 | 175.37M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.11% | 1,496,500 | 118.90M | Jun 29, 2026 |
| J.P. Morgan Fleming Mutual Fd. Group, Inc.-JPMorgan Mid Cap Value Fd. | 1.10% | 1,475,978 | 117.27M | Jun 29, 2026 |